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Antimicrobial efficacy against 
Pseudomonas aeruginosa biofilm 
formation in a three-dimensional 
lung epithelial model and the 
influence of fetal bovine serum
Aurélie Crabbé1,2, Yulong Liu2, Nele Matthijs1, Petra Rigole1, César De La Fuente-Nùñez3,†,‡,#,$, 
Richard Davis2, Maria A. Ledesma2, Shameema Sarker2, Rob Van Houdt4, Robert E. W. Hancock3, 
Tom Coenye1,§ & Cheryl A. Nickerson2,5,§
In vitro models that mimic in vivo host-pathogen interactions are needed to evaluate candidate drugs 
that inhibit bacterial virulence traits. We established a new approach to study Pseudomonas aeruginosa 
biofilm susceptibility on biotic surfaces, using a three-dimensional (3-D) lung epithelial cell model.  
P. aeruginosa formed antibiotic resistant biofilms on 3-D cells without affecting cell viability. The 
biofilm-inhibitory activity of antibiotics and/or the anti-biofilm peptide DJK-5 were evaluated on 3-D 
cells compared to a plastic surface, in medium with and without fetal bovine serum (FBS). In both 
media, aminoglycosides were more efficacious in the 3-D cell model. In serum-free medium, most 
antibiotics (except polymyxins) showed enhanced efficacy when 3-D cells were present. In medium with 
FBS, colistin was less efficacious in the 3-D cell model. DJK-5 exerted potent inhibition of P. aeruginosa 
association with both substrates, only in serum-free medium. DJK-5 showed stronger inhibitory 
activity against P. aeruginosa associated with plastic compared to 3-D cells. The combined addition 
of tobramycin and DJK-5 exhibited more potent ability to inhibit P. aeruginosa association with both 
substrates. In conclusion, lung epithelial cells influence the efficacy of most antimicrobials against  
P. aeruginosa biofilm formation, which in turn depends on the presence or absence of FBS.
The opportunistic pathogen Pseudomonas aeruginosa is one of the leading causes of acute and chronic respira-
tory infections1–5. Intrinsic, acquired, and adaptive antibiotic resistance makes P. aeruginosa particularly chal-
lenging in the clinic6. Furthermore, during chronic lung infections, such as in individuals with cystic fibrosis, 
P. aeruginosa forms biofilms – a phenotype that contributes to high (adaptive) antibiotic resistance and mediates 
long-term host colonization7,8. Therefore, novel antimicrobial approaches that target bacterial virulence factors 
(such as those regulating biofilm formation) or host factors (such as immune stimulation) represent promising 
alternatives to antibiotics, especially given the global problem of antibiotic resistance9,10. When assessing the clinical 
potential of novel antimicrobial agents, mimicking the in vivo bacterial phenotype and incorporating key aspects 
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of host tissues are essential11–13. Indeed, the more closely in vivo host-pathogen interactions are reflected in a model 
system, the more relevant the experimental outcome will be to the patient. During the natural course of infection, 
mucosal pathogens encounter host factors that can act as regulatory signals, and may be beneficial or detrimental 
for the initiation and development of a successful infection11,12,14–18. The collection of host biochemical cues and 
biophysical forces that pathogens might encounter during an infection is termed the host microenvironment. The 
microenvironment includes multiple host cell types, factors produced by these cells (such as cytokines from epithe-
lial cells and other innate immune cells) or resident microbiota, extracellular matrix (ECM) components (proteins, 
growth factors, and other signaling molecules), and physical forces (such as tensile forces and fluid-shear). While it is 
well known that certain host factors (such as stress hormones) affect the growth, biofilm formation and virulence of 
P. aeruginosa19,20, there is still limited knowledge on the influence of lung epithelial cells on the efficacy of antimicro-
bial agents. An additional factor to consider when studying the influence of host cells on antimicrobial agent efficacy 
in vitro is the cell culture medium. While cell culture media have been developed to mimic the chemical composition 
of the in vivo microenvironment, they contain components that are not necessarily found at the mucosal barrier but 
may be important for cell growth and differentiation. One such compound is fetal bovine serum (FBS), which is a 
conventional cell culture supplement needed for the growth of many cell lines, including for lung adenocarcinoma 
A549 cells21,22. This is of particular interest when evaluating antimicrobial agent efficacy as serum has been shown to 
inhibit the efficacy of antibiotics and peptides23,24.
Three-dimensional (3-D) lung epithelial models have been shown to reflect key aspects of the parental tissue, 
including 3-D architecture, barrier function, apical-basolateral polarity, secretion of mucins, and multicellular 
complexity11,21,22,25. All of these phenotypic traits are of importance in mucosal immunity, and play a role during 
interactions of P. aeruginosa with the host12. An established approach to generate organotypic 3-D lung models 
is using a low fluid-shear optimized suspension culture technology, designated as the rotating wall vessel (RWV) 
bioreactor. Previously, a RWV-derived 3-D lung epithelial model was developed by culturing A549 cells on the 
surface of collagen I-coated porous microcarrier beads21. In addition to the above-mentioned in vivo-like char-
acteristics of normal cells, the 3-D epithelial model that was derived from A549 cells showed lower expression of 
cancer markers when compared to conventional A549 monolayers, thus reflecting a more normal differentiated 
tissue phenotype. Using the 3-D A549 lung model, Carterson et al. (2005) demonstrated an infection profile with 
P. aeruginosa that was more relevant to the in vivo scenario, with regards to bacterial adhesion and invasion, and 
host-secreted cytokines. Three-dimensional cell culture models of other tissues that mimic in vivo-like character-
istics have been found to mimic drug sensitivity patterns observed in vivo, including penetration into target tis-
sues and drug resistance, and to more closely parallel patient responses to treatment as compared to conventional 
monolayers and in vivo animal models26–30. However, to our knowledge, RWV-derived 3-D cell culture models 
have not yet been applied for testing the efficacy of antimicrobial agents in the context of infectious diseases.
This study applies the 3-D A549 lung epithelial model as a novel platform to study the influence of lung epi-
thelial cells on antimicrobial agent efficacy against a clinically problematic microorganism. The objectives of this 
study were three-fold: (i) Development of an approach to obtain P. aeruginosa biofilms associated with 3-D A549 
lung epithelium, to more closely approximate both the in vivo bacterial and host phenotypes, (ii) Examination of 
the influence of lung epithelial cells on the ability of commonly used antibiotics as well as a novel antimicrobial 
agent to inhibit the initial stage of biofilm formation by comparing adhesion/association with 3-D epithelial cells 
and with a plastic surface, and (iii) Assessment of the influence of a conventional cell culture supplement (FBS) on 
the obtained results. The novel antimicrobial agent tested was the anti-biofilm peptide DJK-5, which inhibits bio-
film formation and eradicates preformed biofilms constructed from a wide range of microorganisms, including P. 
aeruginosa, on abiotic surfaces and invertebrate in vivo models31. DJK-5 is a D-enantiomeric cationic peptide that 
exerts its anti-biofilm function through degradation of the stringent stress response signal ppGpp31. Synergistic 
activity between DJK-5 and several antibiotics (including tobramycin) has been demonstrated31.
In the present study, we found that P. aeruginosa formed biofilms on 3-D A549 lung epithelial cells that could 
not be eradicated with high concentrations of antibiotics, hereby mimicking aspects of the in vivo bacterial phe-
notype. Biofilms associated with 3-D lung epithelial cells did not affect epithelial cell viability for at least seventeen 
hours, or the formation of tight junctions for at least six hours of infection. Then, our novel biofilm approach was 
used to study P. aeruginosa biofilm inhibition by antimicrobial agents in a model system that mimics aspects of 
the in vivo host tissue, which may be of importance when investigating the early stages of host-pathogen inter-
actions in the context of establishing chronic lung disease (such as in patients with cystic fibrosis). Experiments 
were conducted both in the presence and absence of 10% FBS to evaluate the effect of this commonly used cell 
culture supplement on differential antimicrobial agent efficacy. The results point to significant differences between 
the efficacy of certain antibiotics and DJK-5 against P. aeruginosa biofilms formed on 3-D lung epithelial cells as 
compared to a plastic surface. In addition, we report that the differential efficacy of certain antibiotics and DJK-5 
was influenced by the presence of FBS. These findings highlight the role of the host and its microenvironment in 
the efficacy of antimicrobial agents, as well as the usefulness of the 3-D lung biofilm model as a complementary 
tool for the evaluation of novel antimicrobial compounds.
Results
P. aeruginosa formed biofilms on 3-D lung epithelium. GFP-expressing P. aeruginosa microcolonies 
were observed at the apical surface of 3-D A549 epithelial cells after 2 h and 6 h of infection (Fig. 1A, panels d and e). 
At 17 h post-infection, biofilm-like structures covered a large part of the 3-D epithelial cell surface (Fig. 1A, panel 
f). The formation of biofilm-like structures was confirmed by scanning electron microscopy (SEM) analysis at 
the 6 h time point, and indicated the association of bacteria in a matrix (Fig. 1B). In addition, the number of 
host-associated P. aeruginosa cells increased over time, and the increase in host-associated bacterial numbers 
was different from the increase in the number of planktonic cells between 2 h and 6 h of infection (Fig. 1C,D). 
Indeed, the host-associated P. aeruginosa population increased on average by 2.6-fold between 2 h and 6 h, while 
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the bacterial population that was not host-associated increased 18.0-fold between 2 h and 6 h (p < 0.05). Between 
6 h and 17 h of infection, the increase in the host-associated bacterial population and planktonic populations was 
not significantly different (p > 0.05). This suggests that the increase in host-associated P. aeruginosa may in part 
be independent of growth of the planktonic bacteria present in the surrounding cell culture medium.
P. aeruginosa biofilms on 3-D lung epithelium did not affect host cell viability for up to 17 h of 
infection. We observed that P. aeruginosa biofilms associated with 3-D lung epithelial cells did not significantly 
affect host cell viability for up to 17 h post-infection, as determined by assessing Trypan blue exclusion (more than 
97% viability) (Fig. 2A) and cytosolic lactate dehydrogenase (LDH) release (less than 7% cell death) (Fig. 2B).
Figure 1. P. aeruginosa formed biofilm-like structures on 3-D lung epithelial cells. (A) 3-D lung epithelial 
cells co-cultured without (a–c) or with (d–f) GFP-expressing P. aeruginosa PAO1 for 2 h, 6 h and/or 17 h. 
Immunofluorescence and light microscopy images at a magnification of 400x are overlaid. (B) Scanning 
electron microscopy images of P. aeruginosa biofilms (white dotted frame) at the 6 h infection time point 
with a magnification of 500x (left image) and 10,000x (right image) (C) Number of colony forming units 
(CFUs) adhering to the 3-D lung epithelial cells at different time points. (D) Number of CFUs present in the 
surrounding medium (not associated to host cells).
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Tight junctions were maintained during initial infection time points. The overall integrity of the 
3-D tissue was maintained over the 17 h duration of the experiment, with limited detachment of the cells from 
their micro-carrier bead scaffolds (Fig. 1A, panels a-c for uninfected cells, panels d-f for infected cells). Starting at 
18 h post-infection, cells significantly detached from the scaffold (Supplementary Figure 1). We assessed whether 
Figure 2. Effect of P. aeruginosa biofilms on host cell viability and tight junction formation in 3-D lung epithelial 
cells, following infection for 2 h, 6 h, and 17 h (as compared to uninfected controls): (A) Trypan blue exclusion 
assay. (B) LDH release assay. LDH release is presented as a percentage of a positive control (3-D lung epithelial cells 
lysed with Triton-X100). (C) Immunofluorescence imaging of the tight junctional marker β -catenin (green) for 
uninfected controls (a–c) and infected samples (d–f), at a magnification of 400x. NS = non-significant (p > 0.05).
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epithelial barrier function was maintained during the infection process by immunofluorescence profiling of the 
tight junctional protein β -catenin. A honey-comb expression pattern of β -catenin was observed at 2 h and 6 h 
post-infection, comparable to the matched time point non-infected control (Fig. 2C). At the 17 h infection time 
point, the pattern of expression of β -catenin was lost (Fig. 2C), which might explain the subsequent detachment 
of host cells from their scaffold at later time points. Accordingly, subsequent biofilm studies were performed at 
6 hours.
Biofilms formed on 3-D lung epithelial cells and on plastic could not be eradicated with high 
concentrations of antibiotics. Next, we tested the susceptibility of biofilms associated with 3-D lung cells 
and with plastic to antibiotics. For this purpose, biofilms grown for 6 h on 3-D lung epithelial cells or on plas-
tic were exposed to high concentrations of antibiotics (gentamicin, amikacin, and colistin; between 3-fold and 
60-fold the MIC). Neither biofilms associated with 3-D lung epithelial cells nor those associated with plastic could 
be eradicated using high concentrations of the tested antibiotics (Fig. 3) [for gentamicin at 50 μ g/mL (3x MIC) 
and 500 μ g/mL (31x MIC), for amikacin at 50 μ g/mL (6x MIC) and 500 μ g/mL (60x MIC), and for colistin at 
50 μ g/mL (12.5x MIC)].
The biofilm-inhibitory activity of conventional antibiotics against P. aeruginosa was altered 
when biofilms were formed on 3-D lung epithelial cells compared to plastic. We applied the 3-D 
lung biofilm model to assess the role of differentiated host cells on the efficacy of antibiotics that are commonly 
used to treat chronic P. aeruginosa lung infections. For these experiments, cell culture medium was used that con-
tained 10% FBS (the same as that used for the generation of the 3-D lung epithelial model). The biofilm-inhibitory 
activity of antibiotics commonly used to treat cystic fibrosis patients was determined based on the number of 
bacteria (CFU/mL) that associated with 3-D lung epithelial cells or plastic in the presence or absence of antibi-
otics over a period of six hours. All three aminoglycosides tested (i.e., tobramycin, amikacin and gentamicin) 
more effectively inhibited P. aeruginosa association with 3-D cells than with plastic (Fig. 4A). In contrast, colistin 
less effectively inhibited P. aeruginosa association with 3-D lung cells compared to plastic. The effects of another 
polymyxin (polymyxin B), ceftazidime and ciprofloxacin were similarly effective in both test conditions (Fig. 4A).
FBS influences the differential efficacy of antimicrobial agents against biofilms on 3-D lung 
epithelial cells or plastic. Next, the influence of FBS was assessed on the differential efficacy of antibiotics 
against biofilms associated with 3-D lung epithelial cells or plastic. First, select key phenotypic characteristics 
of the new biofilm approach were validated in medium without FBS for the 6 h incubation time point. The data 
demonstrates that FBS does not strongly influence (i) the bacterial association (log CFU/mL) to 3-D lung epithe-
lial cells or plastic in the absence of antimicrobial agents, (ii) LDH release following infection, (iii) formation of 
biofilm-like structures on both models, and (iv) reduced susceptibility of the biofilms to most tested antibiotics 
(Supplementary data Fig. 2). For the latter, the only exception is colistin, to which biofilms associated with 3-D 
lung epithelial cells and plastic were more susceptible in the absence of FBS (~3 logs survival) compared to that 
observed in the presence of FBS (~5 logs survival), However, the high resistance to the other antibiotics suggests 
that bacteria grown in medium without FBS also form biofilms. It was observed that FBS influences the efficacy of 
certain antibiotics against biofilm formation on plastic and/or 3-D cells (Supplementary Figure 3).
With regard to the differential efficacy of antibiotics against biofilms associated with 3-D lung epithelial 
cells or plastic, most of the tested antibiotics showed an enhanced efficacy in the presence of 3-D lung epithelial 
cells in FBS-free medium (Fig. 4B), with the exception of the polymyxins (colistin and polymyxin B) for which 
no differences between either of the two models were observed. Of note, we initially tested the same antibiotic 
Figure 3. P. aeruginosa biofilms associated to 3-D lung epithelial cells could not be eradicated with high 
concentrations of antibiotics. P. aeruginosa biofilms formed after 6 h on plastic or 3-D lung epithelial cells were 
exposed to high concentrations of gentamicin (50 μ g/mL = 3x MIC, 500 μ g/mL = 31x MIC), amikacin  
(50 μ g/mL = 6x MIC, 500 μ g/mL = 60x MIC) and colistin (50 μ g/mL = 12.5x MIC) for an additional 17–18 h to 
assess their susceptibility to antibiotics. Control biofilms on plastic and 3-D cells were incubated for the same 
duration without antibiotics. Gm = Gentamicin, Col = colistin, Am = amikacin. NS = non-significant (p > 0.05).
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concentrations as those used for medium with FBS (i.e., concentrations were chosen to obtain at least one log of 
inhibition for biofilms associating with 3-D cells). For the aminoglycosides, the additive effect of 3-D epithelial 
cells could not be observed at these concentrations. However, when lowering the aminoglycoside concentration, 
3-D lung epithelial cells enhanced the efficacy of these antibiotics (Fig. 4B), as was observed in medium with FBS 
(Fig. 4A).
The anti-biofilm peptide DJK-5 had a differential efficacy in inhibiting P. aeruginosa associa-
tion with 3-D lung epithelial cells and plastic, and its efficacy was influenced by fetal bovine 
serum. The efficacy of the recently developed anti-biofilm peptide DJK-5 was tested, alone and in combination 
with the antibiotic tobramycin. The efficacy of DJK-5, tobramycin and their combination was initially assessed, 
after 6 hours, in influencing P. aeruginosa association with 3-D lung epithelial cells and plastic in cell culture 
medium (GTSF-2) containing 10% FBS. Bacterial association with 3-D cells or plastic was slightly affected by 
50 μ g/mL DJK-5 (Fig. 5A), a concentration that corresponds to ~50x the MBIC (Minimal biofilm inhibitory 
concentration, tested on plastic) in BM2 minimal medium31. Despite the slight effect of DJK-5 in the presence of 
10% FBS, this antimicrobial agent significantly decreased the bacterial association with 3-D lung epithelial cells 
(p < 0.05) when compared to the no treatment control, both with (2.8-fold, 64% decrease) and without tobra-
mycin (1.5-fold, 33% decrease). At the tested concentration, tobramycin alone did not significantly inhibit the 
formation of P. aeruginosa biofilms associated with 3-D cells compared to the no treatment control (p > 0.05). The 
effect of tobramycin and DJK-5 on 3-D cells appeared to be additive (Fig. 5A). In contrast, a modest (< 2-fold) 
increase in association with a plastic surface was observed with all agents including their combination (Fig. 5A).
Since serum is not present in the natural environment of epithelial cells and has been shown to affect the effi-
cacy of certain antimicrobial agents, including peptides23, the experiment was repeated in cell culture medium 
that did not contain FBS (0% FBS). Of note, the concentration of tobramycin was slightly adjusted to obtain 
similar biofilm-inhibitory effects in the 0% (1 μ g/mL) (Fig. 5B) and 10% (2 μ g/mL) (Fig. 3) medium conditions.
Figure 4. Inhibition of P. aeruginosa association with 3-D lung epithelial cells or plastic by conventional 
antibiotics. Inhibition of association by the antimicrobial compounds was tested in cell culture medium 
that contained 10% FBS (A) or in medium without FBS (B). Data is presented as log inhibition of bacterial 
association compared to the control that received no treatment. Cef = ceftazidime, Col = colistin, 
Pol = polymyxin B, Cip = ciprofloxacin, Am = amikacin, Tb = tobramycin, Ge = Gentamicin. *p < 0.05, 
**p < 0.01, NS = non-significant (p > 0.05). Standard error bars are presented, n ≥ 3.
www.nature.com/scientificreports/
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In the absence of FBS, DJK-5 exerted potent inhibition of P. aeruginosa association with 3-D lung epithelial 
cells and with plastic, reducing cell numbers by 100- and 3,000-fold respectively (Fig. 5B). Stronger inhibitory 
activity of DJK-5 against P. aeruginosa association with plastic was observed as compared to 3-D lung epithelial 
cells, both in the absence and presence of tobramycin (Fig. 5B). The combined activity of tobramycin and DJK-5 
was higher (resulting in a 10,000 to 150,000-fold reduction in bacterial counts associated with plastic and 3-D 
cells, respectively) than the sum of the activity of the individual agents, both for association with 3-D cells and 
plastic (p < 0.05 and p < 0.01, respectively).
DJK-5 demonstrated biofilm-inhibitory activity on plastic and 3-D cells. As shown in Fig. 5, DJK-5 
inhibited P. aeruginosa association with 3-D lung epithelial cells after 6 hours, both in the presence and absence 
of 10% FBS. We subsequently determined whether DJK-5 inhibited biofilm formation at 6 hours on 3-D lung 
epithelial cells and plastic using microscopy for the qualitative assessment of biofilm formation, based on the 
observation of fluorescent cell clusters.
In no FBS medium, DJK-5 alone and in combination with tobramycin showed strong inhibitory activity in 
blocking the formation (or increasing the dispersal) of biofilms on plastic (Fig. 6A, upper panels) and 3-D cells 
(Fig. 6B, upper panels). Even in the presence of 10% FBS, the combination of DJK-5 and tobramycin substan-
tially reduced the formation of P. aeruginosa biofilms on 3-D lung epithelial cells (Fig. 6B, lower panels). Biofilms 
formed on plastic in the presence of DJK-5 and tobramycin in 10% FBS medium were drastically altered in 
structure, with compact patchy cell clusters as opposed to a more homogenous surface coverage in the untreated 
control (Fig. 6A). These findings suggested that despite differences in the efficacy of DJK-5 in inhibiting bacterial 
association with plastic and 3-D cells (Fig. 5), biofilm-inhibitory activity occurred under both circumstances 
(Fig. 6).
Figure 5. Inhibition of P. aeruginosa association with 3-D lung epithelial cells versus plastic by the anti-
biofilm peptide DJK-5, tobramycin and their combination. Inhibition of association of bacteria with these 
surfaces by the antimicrobial compounds was tested in cell culture medium that contained 10% FBS (A) or no 
FBS (B). Data is presented as log inhibition of bacterial association compared to the control that received no 
treatment. Tb = tobramycin. *p < 0.05, **p < 0.01. Standard error bars are presented, n ≥ 3.
www.nature.com/scientificreports/
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Discussion
Accurately predicting the efficacy of antimicrobial agents for treatment of bacterial infections will be improved by 
the availability of model systems that replicate both the bacterial and host in vivo phenotypes11–13. In the present 
study, we developed a novel approach to study interactions between P. aeruginosa biofilms and biotic surfaces, by 
generating biofilms associated with in vivo-like 3-D lung epithelial cells. The 3-D lung epithelial model was previ-
ously shown to have phenotypic traits of the parental tissue, including barrier function, polarity, and multicellular 
complexity21,22,25. Not only are these phenotypic characteristics essential for mucosal immunity, they also play 
an important role in the host colonization of P. aeruginosa12,32–34. For example, polarized epithelial cells are rela-
tively resistant to P. aeruginosa invasion, in contrast to non-polarized, damaged epithelial cells in which invasion 
typically can be observed33,35–37. Therefore, it is anticipated that in vitro model systems that mimic aspects of the 
parental tissue will result in a colonization profile of P. aeruginosa that better reflects the in vivo infectious disease 
scenario. Indeed, previous work demonstrated that a 3-D colonic epithelial model infected with the enteric path-
ogen Salmonella enterica serovar Typhimurium replicated the in vivo disease-associated characteristics of both 
the host and the pathogen38,39.
Besides mimicking the phenotypic traits of lung tissue, our approach also replicates the biofilm phenotype of 
P. aeruginosa that is typically observed during chronic lung infections7. P. aeruginosa formed biofilm-like clus-
ters on the 3-D lung epithelial cells that increased in size over the duration of the infection. The biofilm-like 
structures could not be eradicated with high concentrations of antibiotics, a well-described feature of biofilms7, 
which further indicates that the observed structures were indeed biofilms. Biofilm cells were encased in a matrix, 
Figure 6. Qualitative assessment of antimicrobial agent activity against P. aeruginosa biofilm formation on 
plastic (A) or 3-D lung epithelial cells (B), in the presence and absence of 10% FBS. Epifluorescence (A) and 
an overlay of light microscopy and epifluorescence images (B) were obtained at a magnification of 300x. Scale 
bar = 400 μ m.
www.nature.com/scientificreports/
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which could be derived from the host and/or the bacteria. The 3-D lung epithelial model used in this study 
has a well-defined apical mucus layer that contains the respiratory mucins MUC5AC and MUC121,22. Since 
host-produced factors, such as mucins, play a role in P. aeruginosa biofilm formation40, the presence of a mucus 
layer in the 3-D lung epithelial model may have contributed to biofilm formation by P. aeruginosa. It remains to 
be determined whether P. aeruginosa biofilms are attached to the epithelial cells or are present as non-attached 
aggregates in the mucus layer of the lung epithelial cells; the latter is a phenotype observed in the lung mucus of 
cystic fibrosis patients41. Of note, both biofilm phenotypes have previously been demonstrated to exert similar 
responses to antibiotics and phagocytes42.
A key hallmark of biofilms is their long-term presence on mucosal surfaces. A major challenge with studying 
P. aeruginosa biofilms in vitro in the presence of host cells is massive host cell death and detachment from the 
scaffold following 6–8 hours of infection, which precludes longer term biofilm studies43–45. These previous stud-
ies generated P. aeruginosa biofilms on host cells grown on plastic or on filter inserts. In contrast, generating P. 
aeruginosa biofilms on 3-D lung epithelial cells did not result in cell death or significant cell detachment from the 
microcarrier bead scaffolds over a period of seventeen hours. However, at the 17 h time point, barrier function 
was lost, as determined by imaging of the tight junctional marker β -catenin. Indeed, P. aeruginosa produces a 
range of virulence factors that damage barrier function46–48. In agreement with our findings, 3-D cell cultures of 
different cell lines demonstrated enhanced robustness and/or recovery following infection, as compared to their 
respective monolayer controls21,38,49.
Use of the 3-D lung epithelial model for studying antibiotic efficacy against P. aeruginosa biofilm formation 
revealed significant differences with a static abiotic biofilm model, which is one of the most commonly used bio-
film assays. It is important to note that current MIC assays that are often used for drug discovery do not mimic 
the host environment and thus have somewhat limited predictive value50. While we consider that the system 
described here is closer to the in vivo situation, it is currently not suitable as a primary screening system but might 
have value as a secondary screen.
Previous studies demonstrated that established biofilms associated with different types of epithelial cells con-
sistently demonstrated high resistance to antibiotics43–45,51, a phenotype that we confirmed in the present study. 
In addition, P. aeruginosa biofilms pre-formed on cystic fibrosis bronchial epithelial (CFBE) cells were previ-
ously found to exert enhanced tolerance to antimicrobial agents as compared to biofilms grown on plastic43,44. A 
recent study demonstrated that the synergistic effects of mannitol in combination with tobramycin for eradica-
tion of P. aeruginosa biofilms pre-formed on a plastic surface could not be observed on biofilms pre-formed on 
CFBE cells52. Recently, biofilm formation by P. aeruginosa was found to be inhibited by an antimicrobial peptide 
(WLBU2) both when biofilms were formed on plastic or on CFBE cells53. However, this study did not compare 
the peptide efficacy in both model systems.
We found that when P. aeruginosa associated with host cells as compared to a plastic surface, the efficacy of 
certain antimicrobial agents was different at inhibiting the formation of biofilms. Moreover, the differential effi-
cacy on plastic versus host cells of certain antibiotics depended on the presence or absence of FBS (a conventional 
cell culture supplement) in the culture medium. With the exception of the polymyxins, the tested antibiotics 
showed enhanced efficacy in the presence of 3-D lung epithelial cells, in medium with FBS, in medium without 
FBS, or in both media. It could be hypothesized that antimicrobial compounds produced by respiratory epithelial 
cells (including A549 cells)54,55, such as defensins, may act in synergy with these antibiotics56,57. However, the 
expression of antimicrobial compounds in the 3-D A549 lung model will need to be determined to assess their 
potential role in the observed increased efficacy of aminoglycosides.
FBS inhibited the efficacy of DJK-5 and several antibiotics at the initial bacterial association level. In agree-
ment with these findings, serum was previously found to inhibit the activity of antibiotics and cationic pep-
tides23,24. Apart from the relevance of these findings in the choice of cell culture media and supplements when 
studying antimicrobial agent efficacy in vitro, they might also be relevant for cystic fibrosis patients with hemop-
tysis (~4%)58. Indeed, the presence of blood in the respiratory tract of these patients may influence the efficacy of 
antimicrobial agents. Nevertheless, the inhibition of bacterial association with epithelial cells by DJK-5 could still 
be observed in the presence of 10% FBS, and there appeared to be an additive effect with tobramycin. This might 
be related to the strong ability of DJK-5 to promote biofilm dispersal31 since dispersed cells, being planktonic, 
would no longer be adaptively resistant to antibiotics.
Interestingly, although the activity of DJK-5 in the absence of serum appeared more effective on 
plastic-adhered cells than those associated with the 3-D lung epithelial model, it was nevertheless able to influ-
ence both initial association with epithelial cells and biofilm growth. Furthermore, its efficacy increased substan-
tially in combination with a low concentration of tobramycin.
In conclusion, our study demonstrated that epithelial cells influence the inhibition of bacterial association by 
antimicrobial agents (including commonly used antibiotics), and that this differential inhibition is in turn influ-
enced by a common cell culture supplement, FBS. These findings highlight differences between biofilm model 
systems, as well as the usefulness of in vitro models that reflect key host characteristics. In future studies, mapping 
the host factors that increase or decrease the efficacy of antibiotics might provide novel therapeutic avenues aimed 
at modulating the host to improve treatment success.
Experimental Procedures
Bacterial strains, growth media and conditions. P. aeruginosa PAO1 (ATCC 15692) was kindly pro-
vided by Pierre Cornelis (Vrije Universiteit Brussel, Belgium) and cultured in Luria Broth (LB) overnight at 37 °C, 
250 rpm for all studies. Prior to infection, overnight cultures of P. aeruginosa were centrifuged and resuspended in 
host cell culture media, i.e. GTSF-2 medium (Hyclone, Logan, UT) supplemented with 2.5 mg/L insulin transfer-
rin sodium selenite (ITS) (Sigma-Aldrich), 1.5 g/L sodium bicarbonate (Sigma-Aldrich), and 0% or 10% heat-in-
activated FBS as indicated (Invitrogen).
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For live imaging of P. aeruginosa biofilms on the surface of host cells, an isogenic GFP-expressing P. aerugi-
nosa was constructed as previously described59. Briefly, P. aeruginosa PAO1 was grown overnight at 37 °C in LB 
medium, washed with and resuspended in 300 mM sucrose solution at room temperature. Approximately 3 × 108 
CFUs of resuspended bacteria were transferred to an electroporation cuvette (2 mm gap) to which 100 ng of 
plasmid pUC18R6K-mini-Tn7T-Km-gfp and 100 ng of plasmid pTNS2 was added. After electroporation (2.5 kV, 
5 ms), 1 mL LB was added where after the suspension was incubated for 1 h at 37 °C. Next, GFP-expressing P. 
aeruginosa colonies were isolated on LB agar with 50 μ g/mL kanamycin. P. aeruginosa-GFP growth and associ-
ation with 3-D lung epithelial cells was similar to the wild type strain for the duration of the experiment, except 
for the 17 h time point where the PAO1-GFP strain showed slightly lower association (Supplementary Figure 4).
Antibiotics and antimicrobial peptide. The following antimicrobial agents were used in this study: the 
antibiotics tobramycin, gentamicin, amikacin, ceftazidine, colistin, polymyxin B and ciprofloxacin; and the cat-
ionic anti-biofilm peptide DJK-531. Antibiotics were purchased from Sigma-Aldrich or TCI, while DJK-5 was 
manufactured to 95% purity as previously described31.
Three-dimensional lung epithelial cell model. The human adenocarcinomic alveolar epithelial cell line 
A549 (ATCC CCL-185) was used to generate a 3-D lung model using the RWV bioreactor, as described previ-
ously21. GTSF-2 medium supplemented with 2.5 mg/L ITS (Sigma-Aldrich), 1.5 g/L sodium bicarbonate, and 
10% heat-inactivated FBS (Invitrogen) (30 min, 56 °C) was used for A549 cell culturing. All cultures were grown 
at 37 °C under 5% CO2 conditions. Infection studies were performed using 3-D cultures grown for 11 to 14 days.
Bacterial association with 3-D lung epithelial cells. Upon maturation of the 3-D lung epithelial cells 
(11–14 days), the culture medium was changed, and aggregates containing 2.5 × 105 cells in 250 μ L per well were 
transferred to 48-well plates. A culture of P. aeruginosa PAO1 grown for 16 hours at 37 °C in LB medium was 
resuspended in GTSF-2 medium and added to the 3-D host cells at an MOI of 30:143. Plates were incubated stati-
cally at 37 °C under 5% CO2 conditions for 2 h, 6 h and 17 h. For 17 h infection studies, cultures were rinsed three 
times with HBSS after 1 hour of infection, where after fresh medium was supplied. This step limited the number 
of bacteria in the culture medium that were not associated with host cells. The rinsing step was not performed at 
earlier time points as bacterial association with 3-D lung epithelial cells with or without rinsing was not signifi-
cantly different.
Following the respective infection times, the content of each well was transferred into new 48-well plates to 
avoid inclusion of bacteria attached to the plastic surface. Association of P. aeruginosa with host epithelial cells 
was assessed as described previously43,51, with modifications. Specifically, following 2 h, 6 h and 17 h infection, 
the 3-D aggregates were rinsed twice with HBSS, exposed to 0.1% Triton-X100, and vigorously pipetted to dis-
rupt P. aeruginosa biofilms and host cells. The resulting mixture was serially diluted and plated on LB agar. Since 
0.1% Triton-X100 lyses host cells and hence releases any intracellular bacteria, adhesion data at 6 h infection 
was compared with data obtained using 0.25% Trypsin-EDTA (which does not lyse host cells). The total CFU/
mL recovered was not statistically different using either agent, thus confirming that P. aeruginosa did not invade 
polarized epithelial cells (Supplementary Figure 5). When indicated, the planktonic fraction of the culture was 
serially diluted and plated on LB agar for determination of CFU/mL.
Inhibition of initial association and biofilm formation. The comparison of bacterial association of bac-
teria with 3-D lung epithelial cells and to plastic in the presence of antimicrobial agents was performed at the 6 h 
time point since we found that both host cell viability and tissue integrity (based on the formation of tight junc-
tions) was maintained at this time point (see results section). The antimicrobial agents were diluted in cell culture 
medium with or without 10% FBS in 48-well plates (total volume 250 μ L/well) that did or did not contain 2.5 × 105 
3-D lung epithelial cells. Antibiotic concentrations were empirically determined to obtain an inhibition of adhe-
sion to 3-D cells of at least 1 log unit (in GTSF-2 medium with 10% FBS): tobramycin 2 μ g/mL, ceftazidime 8 μ g/
mL, colistin 2 μ g/mL, ciprofloxacin 0.125 μ g/mL, gentamicin 8 μ g/mL, amikacin 6 μ g/mL, and DJK-5 50 μ g/mL. 
This approach allowed us to observe potential increases or decreases in antibiotic efficacy against biofilm forma-
tion on 3-D cells versus plastic. In the absence of FBS, additional concentrations of aminoglycosides were tested: 
tobramycin 1 μ g/mL, gentamicin 4 μ g/mL, and amikacin 4 μ g/mL. Following addition of the antimicrobial agents, 
a P. aeruginosa culture grown for 16 hours and resuspended in cell culture medium was added to the 48-well plates 
(that did or did not contain 3-D lung epithelial cells) to obtain ~7.5 × 106 CFU per well. Biofilms were formed 
in the absence or presence of the antimicrobial agents for 6 h in a 37 °C, 5% CO2 incubator, and the number of 
cells associating with 3-D lung epithelial cells was determined as described above. For determination of bacterial 
adhesion to plastic, bacteria were resuspended by vigorous pipetting/scraping in 100 μ L of 0.1% Triton-X solution 
in PBS. Then, the disrupted biofilms were serially diluted and plated on LB agar.
The resulting CFU/mL values were log transformed. To determine the log inhibition of a specific treatment in 
the absence or presence of 3-D lung epithelial cells, the log CFU/mL of the treated biofilm was subtracted from 
the log CFU/mL of the no treatment control condition.
Biofilm eradication assay on 3-D lung epithelial cells or plastic. Biofilms were grown on 3-D lung 
epithelial cells or on plastic as described above for 6 hours. Then, 3-D cells containing biofilms were transferred 
to a new well and rinsed with HBSS. Biofilms formed on plastic were also rinsed with HBSS. Next, fresh medium 
was supplied which contained antibiotics at the following concentrations: gentamicin at 50 μ g/mL (3x MIC) and 
500 μ g/mL (31x MIC), amikacin at 50 μ g/mL (6x MIC) and 500 μ g/mL (60x MIC), and colistin at 50 μ g/mL (12.5x 
MIC). Following addition of antibiotics, biofilms were incubated for an additional 17–18 h at 37 °C under 5% CO2 
conditions, after which bacterial association was determined as described above.
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Light- and fluorescence microscopy. Overall morphology/integrity of 3-D lung epithelial cells, and live 
imaging of GFP-expressing P. aeruginosa biofilms was assessed with an EVOS FL Auto Imaging System (Life 
Technologies) or a Zeiss Axiovert.A1 Inverted Fluorescence Microscope. Imaging was performed with a 10x, 20x 
or 40x objective, and appropriate filter cubes.
Immunofluorescence staining and confocal laser scanning microscopy (CLSM). 3-D lung epithe-
lial cells infected with P. aeruginosa for 2 h, 6 h and 17 h were fixed with 4% paraformaldehyde (PFA) and immu-
nostained as described previously22. The primary antibody used in this study targeted human β -catenin (Abcam, 
#ab6301, 1:100 dilution, unconjugated). A goat anti-mouse secondary antibody conjugated with AlexaFluor488 
was used (Invitrogen A-11029, 1:500 dilution). Cell nuclei were stained with DAPI, incorporated in ProLong 
anti-fade agent (Life Technologies). Imaging was performed using a Zeiss LSM 510 Duo laser scanning micro-
scope with a 40x objective. Image acquisition was done with the Zeiss LSM software package, and image process-
ing with Axiovision 4.7.
Scanning electron microscopy. Qualitative analysis of biofilm formation on the 3-D lung epithelial 
cell model was done with SEM. Samples were prepared as described previously38,49. Briefly, 3-D lung epithe-
lial cells infected for 6 h were fixed with SEM fixative (3% glutaraldehyde and 0.5% PFA in PBS) for a mini-
mum of 24 h. Then, samples were rinsed with filter-sterilized deionized water and visualized with a Philips XL 
30 Environmental SEM (FEI Co., Hillsboro, Oregon). To optimize image quality, chamber pressure was adjusted 
between 1 and 2 Torr.
Lactate dehydrogenase (LDH) assay and trypan blue exclusion assay. Release of cytosolic LDH 
by 3-D lung epithelial cells was measured using a LDH activity assay kit (Sigma-Aldrich). Medium from 3-D 
aggregates infected with P. aeruginosa for 2 h, 6 h and 17 h was centrifuged for 15 minutes at 4680 rpm to remove 
cell debris and bacteria. LDH release was then quantified following the manufacturer’s instructions and a stand-
ard curve using NADH was included. As positive control, 3-D lung epithelial cells containing 2.5 × 105 cells were 
lysed with 0.1% Triton-X100. A trypan blue exclusion assay was also performed to assess host cell death, using 
0.4% trypan blue solution (Sigma-Aldrich) according to manufacturer’s instructions.
Statistical analysis. All experiments were performed at least in biological triplicate, except for SEM and 
CLSM imaging which was performed in biological duplicate. Statistical analysis of quantitative assays was done 
using SPSS statistics software version 23. The Shapiro–Wilk test was used in combination with Q/Q plot analysis 
to verify the normal distribution of the data. For normally distributed data, assessment of equality of variances 
was performed using a Levene’s test, followed by an independent sample t-test. Data sets that were not normally 
distributed were analyzed using a Mann–Whitney test. P-values < 0.05 were considered statistically significant.
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